Literature DB >> 11955827

A kinetic model describing the pharmacokinetics of ethyl glucuronide in humans.

Peter Droenner1, Georg Schmitt, Rolf Aderjan, Holger Zimmer.   

Abstract

The glucuronide conjugation is a minor pathway of ethanol metabolism. The determination of ethyl glucuronide (EG) in serum and urine has gained importance in forensic and other legal decisions. To prospectively calculate the serum concentration of this non-oxidative ethanol metabolite, the computer program developed includes a parameter fitting routine. Multiple ethanol doses can be handled. The mathematical modeling was based on the following assumptions and simplifications, respectively. A single enzyme system is responsible for ethanol conjugation at one distinct site; the distribution of EG into the systemic circulation is delayed; the elimination of EG follows first-order kinetics. The concentration of EG was calculated using three kinetic parameters: a rate constant for the first-order formation of EG from serum ethanol, a transfer constant for an obstructed transfer of EG from the formation site (FS) into the central compartment (CC) and an exponential elimination constant. The program was applied to the data collected from 21 drinking experiments. The fitting algorithm optimized the three kinetic parameters, until the sum of concentration error squares of the data points was minimized. The means+/-standard deviation of the rate constant for the first-order formation of EG from serum ethanol was 0.0011+/-0.0006 h(-1), the transfer constant for an obstructed transfer of EG from the FS into the CC was 0.43+/-0.1996 h(-1) and the exponential elimination constant was 3.0+/-1.45 h(-1). Using the range of these parameters, it is now possible to calculate minimum and maximum serum concentrations of EG based on ethanol doses and drinking times. The comparison of calculated and measured concentrations can prove the plausibility of an alleged ethanol consumption. This can be crucial when the serum ethanol concentration (SEC) itself is not meaningful.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955827     DOI: 10.1016/s0379-0738(02)00025-7

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  12 in total

1.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  Ethyl glucuronide concentrations in beard hair after a single alcohol dose: evidence for incorporation in hair root.

Authors:  Johannes Schräder; Michael Rothe; Fritz Pragst
Journal:  Int J Legal Med       Date:  2012-07-08       Impact factor: 2.686

Review 3.  A critical analysis of alcohol hangover research methodology for surveys or studies of effects on cognition.

Authors:  Richard Stephens; James A Grange; Kate Jones; Lauren Owen
Journal:  Psychopharmacology (Berl)       Date:  2014-03-16       Impact factor: 4.530

4.  Influence of Gilbert's syndrome on the formation of ethyl glucuronide.

Authors:  Laura M Huppertz; Leonie Gunsilius; Christelle Lardi; Wolfgang Weinmann; Annette Thierauf-Emberger
Journal:  Int J Legal Med       Date:  2015-02-14       Impact factor: 2.686

5.  Development and validation of LCMS method for determination of Ethyl Glucuronide (EtG) in urine.

Authors:  S R Santhosh; S Sampath; Anurodh Gupta; Ashwini Kumar; Neha Gupta
Journal:  Med J Armed Forces India       Date:  2021-06-01

6.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

7.  Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.

Authors:  Blair U Bradford; Thomas M O'Connell; Jun Han; Oksana Kosyk; Svitlana Shymonyak; Pamela K Ross; Jason Winnike; Hiroshi Kono; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-12       Impact factor: 4.219

8.  Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain.

Authors:  Susannah S Lewis; Mark R Hutchinson; Yingning Zhang; Dana K Hund; Steven F Maier; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2013-01-21       Impact factor: 7.217

9.  Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake.

Authors:  Claudia C Halter; Sebastian Dresen; Volker Auwaerter; Friedrich M Wurst; Wolfgang Weinmann
Journal:  Int J Legal Med       Date:  2007-06-09       Impact factor: 2.686

10.  Detection of ethyl glucuronide in dried human blood using LC-MS/MS.

Authors:  Eckhard Kaufmann; Andreas Alt
Journal:  Int J Legal Med       Date:  2008-01-05       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.